152 related articles for article (PubMed ID: 35871431)
1. Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.
Motalebzadeh J; Eskandari E
Breast Cancer; 2022 Nov; 29(6):1050-1066. PubMed ID: 35871431
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
3. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
[TBL] [Abstract][Full Text] [Related]
4. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
5. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Shao M; Ma H; Wan X; Liu Y
J Cell Physiol; 2020 Oct; 235(10):6574-6581. PubMed ID: 32020607
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer.
Eskandari E; Motalebzadeh J
Cancer Genet; 2019 Nov; 239():62-74. PubMed ID: 31569063
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
12. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
13. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer.
Zhao D; Dong JT
Noncoding RNA; 2018 Dec; 4(4):. PubMed ID: 30544991
[No Abstract] [Full Text] [Related]
15. Oncogenic long noncoding RNA landscape in breast cancer.
Xu S; Kong D; Chen Q; Ping Y; Pang D
Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
17. BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis.
Barton M; Santucci-Pereira J; Vaccaro OG; Nguyen T; Su Y; Russo J
BMC Cancer; 2019 Oct; 19(1):994. PubMed ID: 31646972
[TBL] [Abstract][Full Text] [Related]
18. Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes.
Jiang L; Yu X; Ma X; Liu H; Zhou S; Zhou X; Meng Q; Wang L; Jiang W
Comput Biol Chem; 2019 Feb; 78():1-7. PubMed ID: 30476706
[TBL] [Abstract][Full Text] [Related]
19. Interplay between LncRNAs and microRNAs in Breast Cancer.
Schwarzenbach H; Gahan PB
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175800
[TBL] [Abstract][Full Text] [Related]
20. Multifaced roles of the long non-coding RNA DRAIC in cancer progression.
Sakurai K; Ito H
Life Sci; 2024 Apr; 343():122544. PubMed ID: 38458555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]